147 related articles for article (PubMed ID: 35170052)
1. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study.
Chong N; Schoenberger H; Yekkaluri S; Fetzer DT; Rich NE; Yokoo T; Gopal P; Manwaring C; Quirk L; Singal AG
Aliment Pharmacol Ther; 2022 Mar; 55(6):683-690. PubMed ID: 35170052
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.
Huang DQ; Fowler KJ; Liau J; Cunha GM; Louie AL; An JY; Bettencourt R; Jung J; Gitto Z; Hernandez C; Lopez SJ; Gupta H; Sirlin CB; Marks RM; Loomba R
Aliment Pharmacol Ther; 2022 Apr; 55(7):820-827. PubMed ID: 35229334
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
Schoenberger H; Chong N; Fetzer DT; Rich NE; Yokoo T; Khatri G; Olivares J; Parikh ND; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1561-1569.e4. PubMed ID: 34119640
[TBL] [Abstract][Full Text] [Related]
4. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.
Simmons O; Fetzer DT; Yokoo T; Marrero JA; Yopp A; Kono Y; Parikh ND; Browning T; Singal AG
Aliment Pharmacol Ther; 2017 Jan; 45(1):169-177. PubMed ID: 27862091
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
Tiyarattanachai T; Fetzer DT; Kamaya A
AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
[No Abstract] [Full Text] [Related]
6. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
Smereka P; Doshi AM; Lavelle LP; Shanbhogue K
AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909
[No Abstract] [Full Text] [Related]
7. Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
Farhang Zangneh H; Wong WWL; Sander B; Bell CM; Mumtaz K; Kowgier M; van der Meer AJ; Cleary SP; Janssen HLA; Chan KKW; Feld JJ
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1840-1849.e16. PubMed ID: 30580095
[TBL] [Abstract][Full Text] [Related]
8. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
9. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
12. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
Curran C; Priest M; Datta S; Forrest EH; Stanley AJ; Barclay ST
Dig Dis Sci; 2023 Mar; 68(3):770-777. PubMed ID: 36376575
[TBL] [Abstract][Full Text] [Related]
14. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
Singal A; Volk ML; Waljee A; Salgia R; Higgins P; Rogers MA; Marrero JA
Aliment Pharmacol Ther; 2009 Jul; 30(1):37-47. PubMed ID: 19392863
[TBL] [Abstract][Full Text] [Related]
16. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
[TBL] [Abstract][Full Text] [Related]
18. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.
Merchante N; Figueruela B; Rodríguez-Fernández M; Rodríguez-Arrondo F; Revollo B; Ibarra S; Galindo MJ; Merino E; Montero M; Téllez F; García-Deltoro M; Rivero-Juárez A; Delgado-Fernández M; Ríos-Villegas MJ; Aguirrebengoa K; García MA; Portu J; Vera-Méndez FJ; Villalobos M; Mínguez C; De Los Santos I; López-Ruz MA; Omar M; Galera C; Macias J; Pineda JA;
AIDS; 2019 Feb; 33(2):269-278. PubMed ID: 30325782
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.
Yang D; Hu H; Li R; Tang CL; Ma KS; Guo DY
Abdom Radiol (NY); 2022 Feb; 47(2):630-639. PubMed ID: 34910237
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
